158 related articles for article (PubMed ID: 19892916)
1. Pharmacological retention of oral mucosa progenitor/stem cells.
Izumi K; Inoki K; Fujimori Y; Marcelo CL; Feinberg SE
J Dent Res; 2009 Dec; 88(12):1113-8. PubMed ID: 19892916
[TBL] [Abstract][Full Text] [Related]
2. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.
Iglesias-Bartolome R; Patel V; Cotrim A; Leelahavanichkul K; Molinolo AA; Mitchell JB; Gutkind JS
Cell Stem Cell; 2012 Sep; 11(3):401-14. PubMed ID: 22958932
[TBL] [Abstract][Full Text] [Related]
3. Isolation of human oral keratinocyte progenitor/stem cells.
Izumi K; Tobita T; Feinberg SE
J Dent Res; 2007 Apr; 86(4):341-6. PubMed ID: 17384029
[TBL] [Abstract][Full Text] [Related]
4. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
Drayer AL; Olthof SG; Vellenga E
Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.
Butzal M; Loges S; Schweizer M; Fischer U; Gehling UM; Hossfeld DK; Fiedler W
Exp Cell Res; 2004 Oct; 300(1):65-71. PubMed ID: 15383315
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of oral mucosa and skin keratinocyte progenitor/stem cells.
Izumi K; Marcelo CL; Feinberg SE
Methods Mol Biol; 2013; 989():293-303. PubMed ID: 23483404
[TBL] [Abstract][Full Text] [Related]
7. Comparative Assessment of Cultures from Oral and Urethral Stem Cells for Urethral Regeneration.
Corradini F; Zattoni M; Barbagli G; Bianchi G; Giovanardi M; Serafini C; Genna VG; Ribbene A; Balò S; Fidanza F; Lazzeri M; Luca M; Pellegrini G
Curr Stem Cell Res Ther; 2016; 11(8):643-651. PubMed ID: 26329484
[TBL] [Abstract][Full Text] [Related]
8. Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes.
Chen J; Liu K; Liu Y; Wang X; Zhang Z
Exp Dermatol; 2019 Mar; 28(3):270-275. PubMed ID: 30650200
[TBL] [Abstract][Full Text] [Related]
9. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
[TBL] [Abstract][Full Text] [Related]
10. Effects of C-xylopyranoside derivative on epithelial regeneration in an in vitro 3D oral mucosa model.
Uenoyama A; Kakizaki I; Shiomi A; Saito N; Hara Y; Saito T; Ohnuki H; Kato H; Takagi R; Maeda T; Izumi K
Biosci Biotechnol Biochem; 2016 Jul; 80(7):1344-55. PubMed ID: 26966997
[TBL] [Abstract][Full Text] [Related]
11. Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling.
Nakamura T; Endo K; Kinoshita S
Stem Cells; 2007 Mar; 25(3):628-38. PubMed ID: 17110619
[TBL] [Abstract][Full Text] [Related]
12. Laser phototherapy accelerates oral keratinocyte migration through the modulation of the mammalian target of rapamycin signaling pathway.
Pellicioli AC; Martins MD; Dillenburg CS; Marques MM; Squarize CH; Castilho RM
J Biomed Opt; 2014 Feb; 19(2):028002. PubMed ID: 24531144
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.
Lee KW; Yook JY; Son MY; Kim MJ; Koo DB; Han YM; Cho YS
Stem Cells Dev; 2010 Apr; 19(4):557-68. PubMed ID: 19642865
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin effects on mTOR signaling in benign, premalignant and malignant human breast epithelial cells.
Kim SH; Zukowski K; Novak RF
Anticancer Res; 2009 Apr; 29(4):1143-50. PubMed ID: 19414357
[TBL] [Abstract][Full Text] [Related]
15. Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes.
DeTemple V; Satzger I; Walter A; Schaper K; Gutzmer R
Exp Dermatol; 2016 Oct; 25(10):775-82. PubMed ID: 27194247
[TBL] [Abstract][Full Text] [Related]
16. Intracellular signals that control cell proliferation in mammalian balance epithelia: key roles for phosphatidylinositol-3 kinase, mammalian target of rapamycin, and S6 kinases in preference to calcium, protein kinase C, and mitogen-activated protein kinase.
Montcouquiol M; Corwin JT
J Neurosci; 2001 Jan; 21(2):570-80. PubMed ID: 11160436
[TBL] [Abstract][Full Text] [Related]
17. Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells.
Juengel E; Engler J; Natsheh I; Jones J; Mickuckyte A; Hudak L; Jonas D; Blaheta RA
BMC Cancer; 2009 May; 9():161. PubMed ID: 19473483
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation.
Salmond RJ; Brownlie RJ; Meyuhas O; Zamoyska R
J Immunol; 2015 Nov; 195(10):4615-22. PubMed ID: 26453749
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
[TBL] [Abstract][Full Text] [Related]
20. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
